HMR-1372

Chemical Name: 5-tert-Butyl-2-methoxy-N-[2-[4-methoxy-3-(3-methylthioureidosulfonyl)phenyl]ethyl]benzamide
CAS No. 260971-17-3, 261717-20-8 (Na salt)
项目整合开发状态: Preclinical
项目研究机构: Aventis Pharma (Originator)
合成路线:Coupling between ethylamine derivative (I) and acid chloride (II) by means of DMAP in pyridine affords benzamide (III),which is then subjected to reaction with chlorosulfonic acid followed by treatment with aqueous ammonia to provide benzenesulfonamide (IV).Finally,the desired product is obtained by condensation of (IV) with methyl isothiocyanate in DMF by means of K2CO3.
📌 参考资料/链接:
参考文献标题:Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers
文献作者:G鰃elein,H.; Bohn,H.; Heitsch,H.; Englert,H.C.; Gerlach,U.; Wirth,K.(Aventis Pharma Deutschland GmbH)
参考来源:DE 19841534; EP 1117409; WO 0015204